Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 9:01 AM ET

Date/Time Source News Release
05/30/2025 07:00 AM EDT Business Wire TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience
05/15/2025 07:00 AM EDT Business Wire TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance
05/12/2025 04:30 PM EDT Business Wire TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call
04/30/2025 08:00 AM EDT Business Wire TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results
03/27/2025 07:30 AM EDT Business Wire TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
03/26/2025 08:00 AM EDT Business Wire TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping
02/03/2025 04:05 PM EST Business Wire TriSalus Life Sciences Announces Key Appointments to Board of Directors
02/03/2025 08:00 AM EST Business Wire TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed
01/23/2025 08:00 AM EST Business Wire TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call
01/09/2025 08:00 AM EST Business Wire TriSalus Life Sciences® Announces Publication of Pre-Clinical Data Demonstrating Improved Delivery of Embospheres® to Liver Tumors using Pressure-Enabled Drug Delivery(TM) (PEDD(TM)) via the TriNav® Infusion System
Page

Additional News

As of June 3, 2025 • 9:01 AM ET

Date/Time Source News Release
05/15/2025 06:46 PM EDT SeekingAlpha TriSalus outlines at least 50% revenue growth for 2025 as new Medicare code expands addressable market
05/15/2025 06:45 PM EDT SeekingAlpha TriSalus Life Sciences, Inc. (TLSI) Q1 2025 Earnings Conference Call Transcript
05/15/2025 08:10 AM EDT Zacks TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
05/15/2025 07:36 AM EDT SeekingAlpha TriSalus Life Sciences GAAP EPS of -$0.39 misses by $0.17, revenue of $9.2M beats by $0.16M
05/15/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 15th, 2025
05/15/2025 05:31 AM EDT US Earnings Reports Expected earnings - TriSalus Life Sciences Inc.
05/12/2025 07:15 PM EDT Zacks OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
05/12/2025 07:45 AM EDT Zacks OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
05/08/2025 06:45 PM EDT Zacks TerrAscend Corp. (TSNDF) Reports Q1 Loss, Lags Revenue Estimates
04/30/2025 08:15 AM EDT Zacks SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.